Texas Instruments forecast third-quarter revenue that missed analysts’ estimates.
Related Posts
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.
De minimis trade loophole that boosted Chinese online retailers to end May 2
The announcement, which came alongside a set of sweeping new tariffs, gives customs officials, retailers and logistics companies a month to prepare.
The mystery math behind Bill Gates’ pledge
Bill Gates has an enviable problem: He can’t give away his money fast enough.